Meye A - Search Results

1

Expression of Ki-67 in squamous cell carcinoma of the penis.

Berdjis N, Meye A, Nippgen J, Dittert D, Hakenberg O, Baretton GB, Wirth MP. Berdjis N, et al. Among authors: meye a. BJU Int. 2005 Jul;96(1):146-8. doi: 10.1111/j.1464-410X.2005.05584.x. BJU Int. 2005. PMID: 15963138

2

Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.

Hoefling C, Schmidt H, Meinhardt M, Lohse A, Taubert H, Fuessel S, Schmidt U, Schuster K, Baretton G, Wirth MP, Meye A. Hoefling C, et al. Among authors: meye a. Int J Mol Med. 2004 Jun;13(6):835-42. Int J Mol Med. 2004. PMID: 15138621

3

Induction of proliferation and differentiation of cultured urothelial cells on acellular biomaterials.

Ram-Liebig G, Meye A, Hakenberg OW, Haase M, Baretton G, Wirth MP. Ram-Liebig G, et al. Among authors: meye a. BJU Int. 2004 Oct;94(6):922-7. doi: 10.1111/j.1464-410X.2004.05061.x. BJU Int. 2004. PMID: 15476537

4

Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma.

Hakenberg OW, Fuessel S, Richter K, Froehner M, Oehlschlaeger S, Rathert P, Meye A, Wirth MP. Hakenberg OW, et al. Among authors: meye a. Urology. 2004 Dec;64(6):1121-6. doi: 10.1016/j.urology.2004.08.019. Urology. 2004. PMID: 15596183

5

Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.

Froehner M, Hakenberg OW, Koch R, Schmidt U, Meye A, Wirth MP. Froehner M, et al. Among authors: meye a. Urol Int. 2006;76(1):27-30. doi: 10.1159/000089731. Urol Int. 2006. PMID: 16401917

6

Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.

Fuessel S, Sickert D, Meye A, Klenk U, Schmidt U, Schmitz M, Rost AK, Weigle B, Kiessling A, Wirth MP. Fuessel S, et al. Among authors: meye a. Int J Oncol. 2003 Jul;23(1):221-8. Int J Oncol. 2003. PMID: 12792797

7

siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.

Ning S, Fuessel S, Kotzsch M, Kraemer K, Kappler M, Schmidt U, Taubert H, Wirth MP, Meye A. Ning S, et al. Among authors: meye a. Int J Oncol. 2004 Oct;25(4):1065-71. Int J Oncol. 2004. PMID: 15375557

8

Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.

Kraemer K, Schmidt U, Fuessel S, Herr A, Wirth MP, Meye A. Kraemer K, et al. Among authors: meye a. Int J Cancer. 2006 Sep 15;119(6):1276-84. doi: 10.1002/ijc.21975. Int J Cancer. 2006. PMID: 16615118

9

Quantitative multi-gene expression profiling of primary prostate cancer.

Schmidt U, Fuessel S, Koch R, Baretton GB, Lohse A, Tomasetti S, Unversucht S, Froehner M, Wirth MP, Meye A. Schmidt U, et al. Among authors: meye a. Prostate. 2006 Oct 1;66(14):1521-34. doi: 10.1002/pros.20490. Prostate. 2006. PMID: 16921506

10

Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient.

Wuttig D, Baier B, Fuessel S, Meinhardt M, Herr A, Hoefling C, Toma M, Grimm MO, Meye A, Rolle A, Wirth MP. Wuttig D, et al. Among authors: meye a. Int J Cancer. 2009 Jul 15;125(2):474-82. doi: 10.1002/ijc.24353. Int J Cancer. 2009. PMID: 19391132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters